Norris ORIEN Total Cancer Care

PRIMARY OBJECTIVES:

I. To establish a longitudinal study of clinical and related data from patients with or at
risk for cancer.

II. To establish a large biospecimen repository that is linked to clinical and related data.

III. To follow patients through their lifetime though passive or active follow-up.

IV. To use clinical data, tissues, other biological samples and derived molecular data in the
Total Cancer Care Protocol (TCCP) repositories to match patients in this TCCP study to future
studies.

OUTLINE:

Patients undergo collection of blood during a regular care visit or not up to 4 times a year.
Extra tissue is collected after removal during standard of care surgery and patients may
undergo additional tumor sampling (needle passes) at the time of planned diagnostic biopsies.
During bone marrow biopsy, the doctor may reposition the needle up to 3 times, and bone
marrow for research will not be collected more than 4 times per year. Patients may undergo
additional collection of other biological samples such as saliva, sputum, urine, feces, hair,
and surface skin swabs for analysis. Patients also receive surveys or questionnaires to
collect demographics, medical, family, and nutritional history, cancer predisposing risk
factors, quality of life data, and quality of care data.

After completion of study, patients are followed up periodically.

Inclusion Criteria:

- Limited to those patients who are registered for outpatient or inpatient care at
University of Southern California (USC) Norris

- Able to understand and sign the TCCP informed consent, California subject's bill of
rights, Health Insurance Portability and Accountability Act (HIPAA), and research
authorization form directly or through an authorized representative; the informed
consent, subject's bill of rights, HIPAA, and research authorization will be available
in both English and Spanish languages

Exclusion Criteria:

- Individuals who are not registered as patients for outpatient or inpatient care at USC
Norris

- Individuals who are unable to understand or sign the TCCP informed consent, subject's
bill of rights, HIPAA, and research authorization in either English or Spanish